tiprankstipranks
Trending News
More News >
Strong Q1 2025 Performance and Raised EBITDA Guidance Justify Buy Rating for GoodRx Holdings
PremiumRatingsStrong Q1 2025 Performance and Raised EBITDA Guidance Justify Buy Rating for GoodRx Holdings
1M ago
GoodRx Holdings Faces Sell Rating Amid Decline in Consumer Growth and Cautious Revenue Outlook
Premium
Ratings
GoodRx Holdings Faces Sell Rating Amid Decline in Consumer Growth and Cautious Revenue Outlook
1M ago
GoodRx reports Q1 adjusted EPS 9c, consensus 10c
Premium
The Fly
GoodRx reports Q1 adjusted EPS 9c, consensus 10c
1M ago
GoodRx Holdings: Strategic Positioning and Cost Advantages Support Buy Rating Amidst Competitive Landscape
PremiumRatingsGoodRx Holdings: Strategic Positioning and Cost Advantages Support Buy Rating Amidst Competitive Landscape
2M ago
GoodRx price target lowered to $5.50 from $6.50 at Truist
Premium
The Fly
GoodRx price target lowered to $5.50 from $6.50 at Truist
2M ago
Cautious Outlook for GoodRx Holdings Amid Limited Partnership Impact and Industry Challenges
Premium
Ratings
Cautious Outlook for GoodRx Holdings Amid Limited Partnership Impact and Industry Challenges
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100